140 related articles for article (PubMed ID: 31504968)
1. Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab.
Yamada H; Kaneko Y; Tamai H; Takeuchi T
Rheumatology (Oxford); 2020 Feb; 59(2):440-442. PubMed ID: 31504968
[No Abstract] [Full Text] [Related]
2. Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease.
Cavalli G; Tomelleri A; De Luca G; Campochiaro C; Dinarello CA; Baldissera E; Dagna L
Arthritis Res Ther; 2019 Feb; 21(1):54. PubMed ID: 30760322
[No Abstract] [Full Text] [Related]
3. Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still's disease.
Yoshida Y; Sakamoto M; Yokota K; Sato K; Mimura T
Intern Med; 2011; 50(16):1757-60. PubMed ID: 21841340
[TBL] [Abstract][Full Text] [Related]
4. [Adult-onset Still's disease].
Dalzotto R; Zenklusen C; Kaeser P
Rev Med Suisse Romande; 1996 Jun; 116(6):459-62. PubMed ID: 8711297
[No Abstract] [Full Text] [Related]
5. Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still's Disease.
Vandemergel X; Vandergheynst F
Acta Medica (Hradec Kralove); 2016; 59(1):22-5. PubMed ID: 27131353
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease.
Forestier E; Pasquali JL
Joint Bone Spine; 2015 Mar; 82(2):136-7. PubMed ID: 25553837
[No Abstract] [Full Text] [Related]
7. Interleukin-18 in adult-onset Still's disease: treatment target or disease activity indicator?
Nagashima T; Iwamoto M; Matsumoto K; Minota S
Intern Med; 2012; 51(4):449; author reply 451. PubMed ID: 22333388
[No Abstract] [Full Text] [Related]
8. Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.
Kaneko Y; Kameda H; Ikeda K; Ishii T; Murakami K; Takamatsu H; Tanaka Y; Abe T; Takeuchi T
Ann Rheum Dis; 2018 Dec; 77(12):1720-1729. PubMed ID: 30279267
[TBL] [Abstract][Full Text] [Related]
9. [Tocilizumab effectiveness in adult Still's disease].
López Buitrago R; Estrada Dorronsoro S; Cervera Segura R; Espinosa Garriga G
Med Clin (Barc); 2012 Jan; 138(1):42-3. PubMed ID: 21605875
[No Abstract] [Full Text] [Related]
10. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases.
Andrade-Ortega L; Irazoque-Palazuelos F; Muñoz-López S; Rosales-Don Pablo VM
Reumatol Clin; 2014; 10(3):199-200. PubMed ID: 24076178
[No Abstract] [Full Text] [Related]
12. Prolonged treatment with Tadekinig alfa in adult-onset Still's disease.
Kiltz U; Kiefer D; Braun J; Schiffrin EJ; Girard-Guyonvarc'h C; Gabay C
Ann Rheum Dis; 2020 Jan; 79(1):e10. PubMed ID: 30352887
[No Abstract] [Full Text] [Related]
13. Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease.
Yoshihara R; Tsuchiya H; Shoda H; Fujio K
Scand J Rheumatol; 2024 Jul; 53(4):284-287. PubMed ID: 38314790
[No Abstract] [Full Text] [Related]
14. Adult onset Still's disease. 16 cases.
Akritidis N; Sakkas LI
Presse Med; 1995 Sep; 24(26):1207-8. PubMed ID: 7567848
[No Abstract] [Full Text] [Related]
15. Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease.
Naniwa T; Ito R; Watanabe M; Hayami Y; Maeda S; Sasaki K; Iwagaitsu S
Clin Rheumatol; 2013 Mar; 32 Suppl 1():S103-6. PubMed ID: 20842515
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease.
Komiya A; Matsui T; Nogi S; Iwata K; Futami H; Takaoka H; Arinuma Y; Hashimoto A; Shimada K; Ikenaka T; Nakayama H; Furukawa H; Tohma S
Scand J Rheumatol; 2012 Mar; 41(2):156-8. PubMed ID: 22420333
[No Abstract] [Full Text] [Related]
17. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
[TBL] [Abstract][Full Text] [Related]
18. A case of adult-onset Still's disease presenting with angioedema.
Soy M
Clin Rheumatol; 2004 Feb; 23(1):92. PubMed ID: 14749997
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 as a diagnostic marker of adult-onset Still's disease in older patients: a case report and review of the literature.
Usuda D; Furumura Y; Takeshima K; Sangen R; Kawai Y; Kasamaki Y; Iinuma Y; Kanda T
J Med Case Rep; 2018 Jul; 12(1):198. PubMed ID: 29986752
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum caeruloplasmin level in a patient with adult Still's disease.
Kemény L; Mehravaran M; Dobozy A
Br J Dermatol; 2002 Mar; 146(3):508-10. PubMed ID: 11952555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
